Detalles de la búsqueda
1.
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Am J Hypertens
; 20(6): 699-704, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17531931
2.
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
Am J Cardiol
; 92(4): 400-5, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12914869
3.
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
Am J Hypertens
; 16(1): 11-20, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12517677
4.
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Int J Cardiol
; 94(2-3): 293-300, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15093996
5.
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment.
Hypertension
; 41(3): 528-33, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12623954
6.
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Hypertension
; 40(1): 61-6, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12105139
Resultados
1 -
6
de 6
1
Próxima >
>>